The medical industry lacks precise and accurate methods to simulate and guide the outcomes of various medical procedures. The tools used today are inefficient, limited, and do not provide an accurate representation of the end-results.

BioMedX has developed the solution to deliver highly-accurate and data-driven simulations that can be applied to a wide variety of applications ranging from medical to gaming, and beyond. Through simulations, more comprehensive approaches can be developed to optimize surgical outcomes, mitigate risks, and enhance recovery time.


BioMedX Group, Inc. is a medical technology company with the goal to improve the efficiencies and outcomes of medical procedures through highly-accurate and data-driven simulations powered by the Company’s X³ 3D Physics Engine.

BioMedX’s technology is developed by former scientists and mathematicians from Johns Hopkins University and has been published in a peer-reviewed journal. The X³ 3D Physics Engine can be deployed in a wide variety of applications to provide simulations that can be used for pre-surgical planning and modeling to optimize the results and mitigate the risks. BioMedX has validated its technology through its first product, the FACIEM³ Aesthetics Simulator, and most recently with Epic Games by becoming a recipient of the Epic Games MegaGrant program.

Through the technologies that BioMedX is developing, the Company seeks to empower both clinicians and patients with knowledge, confidence, and insights to their health, treatment, and recovery.

Management Team

Get to know the team.

Rudy Mazzocchi

Learn more

About Rudy A. MazzocchiCo-Founder / C.E.O

Rudy A. Mazzocchi has over 35 years of Senior Executive Management, Technology and Intellectual Property Development, and Financing Experience (institutional, venture, private and public) in the Med-tech, Biotech, and Biopharma industries. As a founder of over a dozen Healthcare companies, he has developed and commercialized multiple technologies ranging from diagnostics to implantable medical devices, requiring demanding clinical validation and regulatory reviews, including FDA Clearance, CE Mark, and International Regulatory Approvals.

As Chairman/Acting-CEO of AGENTIX Biopharma Corp., he concurrently serves as Executive Chairman of PreIPO Exchange Corp., Co-Founder/CEO of the BioMedX Group, Executive Chairman of MY NEXT HEALTH and Independent Director of several private and public, early, and growth-stage Companies, and Senior Advisor to a variety of International Corporations seeking global expansion and/ or access to U.S. public markets. Rudy previously served as Executive Chairman of Establishment Labs (NASDAQ:ESTA) and Independent Director of Greatbatch/Integer Medical (NYSE:ITGR).

He is the recipient of the Technology Leadership Award, the Businessman of the Year Award, the Ernst & Young Entrepreneur of the Year Award in Healthcare, and Global Entrepreneur of the Year Award. He has also authored more than 100 patents, three published award-winning novels and a top- selling business book on Entrepreneurism.

Juan Carlos Zapata

Learn more

About Juan Carlos ZapataCo-Founder / Chairman

Established venture capitalist with a focus on technology, media, entertainment and film financing, including producing and capital raising

Financed, produced, and distributed over 37 entertainment projects including films, television shows and a Broadway play

Raised capital for several technology companies and brought their products and services into market

Kelvin Chen

Learn more

About Kelvin ChenMarketing Director

Founded 3A Media, a marketing consultancy and delivered the marketing and social media strategies and campaigns for top media companies including MTV, Nickelodeon, NBA etc.

Worked at Viacom Plus and managed major client accounts such as P&G, HP etc. valued at close to $1 billion

Led the marketing efforts of various startups to both investors and consumers

Development Team

Get to know the team.

Raghu Ragahavan, PhD

Learn more

About Raghu Ragahavan, PhDChief Scientist

Founded several companies in the telemedicine, medical simulation and visualization, and data presentation space

A professor who previously taught in the computer science and radiology departments at Johns Hopkins University

Contributed to the development of imaging sensor materials, image analysis integrating models and data, parallel computing, and biomedical simulations, including brain physiology and drug transport

Has over 110 publications in scientific and medical journals

Holds over 20 patent filings to date

Martin Brady, PhD

Learn more

About Martin Brady, PhDChief Engineer

Co-founded Therataxis, LLC where he served as chief engineer

Held position of Algorithm Architect at Neurologics and was a staff research scientist and project manager within the Microcomputer Research Labs at Intel and Lockheed

Was an assistant professor of computer engineering at Penn State for 5 years

Worked mainly in areas of image processing, massively parallel computing, neural networks, computer graphics, and visualization